References
- Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol. 2006;97: 52C–60C
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.
- Sivakumar S. Statin induced myotoxicity. Eur J Int Med. 2012;317: 324
- Klopstock T. Drug-induced myopathies. Curr Opin Neurol. 2008;21: 590–595
- Needham M, Fabian V, Knezevic W, Panegyres P, Zilko P, Mastaglia FL. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007;17: 194–200
- Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010;41: 185–190.
- Hanissian AS, Masi AT, Pitner SE, Cape CC, Medsger TA Jr. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. J Rheumatol. 1982;9: 390–394.
- Padala S, Thompson PD. Statins as a possible cause of inflammatory and necrotizing myopathies. Atherosclerosis. 2011;222: 15–21
- Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep. 2005;57: 23–24.
- Jamal SM, Eisenberg MJ, Christopoulos S. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors. Am Heart J. 2004;147: 956–965
- Moosmann B, Behl C. Selenoprotein synthesis and side-effects of statins. Lancet. 2004;363: 892–894
- Noel B. Autoimmune disease and other potential side-effects of statins. Lancet. 2004;363: 2000
- Emslie-Smith AM, Engel AG. Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration. Neurology.. 1991;41: 936–939
- Mammen AL, Chung T, Christopher-Stine I, Rosen P, Rosen A, Doering KR et al. Autoantibodies against 3-hydroxy-3-methyglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011;63: 713–721